Sonnet Biotherapeutics Holdings Inc. buy Chardan Capital
Start price
23.08.24
/
50%
€0.18
Target price
23.08.25
€26.85
Performance (%)
-
End price
24.08.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sonnet Biotherapeutics Holdings Inc. | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Chardan_Capital for this prediction
In the thread Sonnet Biotherapeutics Hldgs. Inc. diskutieren
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $30.00 price target on the stock.
Ratings data for SONN provided by MarketBeat
In the thread Trading Sonnet Biotherapeutics Hldgs. Inc.
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for Sonnet Biotherapeutics Holdings Inc.
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
20.12.24
20.12.24
€19.21
20.12.25
20.12.25
-
20.11.23
20.11.23
Stopped prediction by Chardan_Capital for Sonnet Biotherapeutics Holdings Inc.
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
07.04.25
07.04.25
€18.22
07.04.26
07.04.26
-
20.11.23
20.11.23
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
28.03.25
28.03.25
€18.53
28.03.26
28.03.26
-
20.11.23
20.11.23
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
28.05.24
28.05.24
€27.57
28.05.25
28.05.25
-
29.05.25
29.05.25
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.18
15.02.24
15.02.24
€27.86
15.02.25
15.02.25
-
16.02.25
16.02.25
Sonnet Biotherapeutics Holdings Inc.
Start price
Target price
Perf. (%)
€0.38
16.08.23
16.08.23
€11.00
16.08.24
16.08.24
-51.06%
17.08.24
17.08.24